{
  "domain": "www.rand.org",
  "crawling_time": "2023-12-22 14:58:15.352549",
  "crawling_time_epoch": 1703231895,
  "type": "Media Advisory",
  "title": "Experts on U.S. Drug Prices and Health Insurance Subsidies Can Address Impact of Inflation Reduction Act",
  "url": "https://www.rand.org/news/advisories/2022/08/08.html",
  "descriptions": "RAND Corporation experts can address the potential health care impacts of the Inflation Reduction Act that was passed by the U.S. Senate on August 7. Those topics include the implications of allowing Medicare to negotiate prices directly with drug manufacturers for some medications, capping Medicare Part D out-of-pocket costs, and continuing enhanced health insurance subsidies for people who buy insurance through Affordable Care Act exchanges.",
  "posted": "Aug 8, 2022",
  "image": {
    "thumb": "https://www.rand.org/content/rand/news/advisories/2022/08/08/_jcr_content/par/teaser.crop.250x187.lt.jpeg/1659993362518.jpeg",
    "desc": "White tablets and orange capsules on top of a U.S. 100 dollar bill with the upper part of Franklin's face visible, photo by cagkansayin/Getty Images"
  },
  "content": {
    "media_relations": {
      "contact1": "(703) 414-4795",
      "contact2": "(310) 451-6913",
      "email": "media@rand.org"
    },
    "sub_content": [
      {
        "Interviews": "To arrange an interview, contact the RAND Office of Media Relations:\n(703) 414-4795 or\n(310) 451-6913, or\nsend an email to media@rand.org."
      }
    ],
    "topics": [
      {
        "url": "https://www.rand.org/topics/government-legislation.html",
        "tag": "Government Legislation"
      },
      {
        "url": "https://www.rand.org/topics/health-care-costs.html",
        "tag": "Health Care Costs"
      },
      {
        "url": "https://www.rand.org/topics/health-insurance-cost-sharing.html",
        "tag": "Health Insurance Cost Sharing"
      },
      {
        "url": "https://www.rand.org/topics/health-legislation.html",
        "tag": "Health Legislation"
      },
      {
        "url": "https://www.rand.org/topics/pharmaceutical-drugs.html",
        "tag": "Pharmaceutical Drugs"
      },
      {
        "url": "https://www.rand.org/topics/united-states.html",
        "tag": "United States"
      }
    ],
    "Article": "August 8, 2022 RAND Corporation experts can address the potential health care impacts of the Inflation Reduction Act that was passed by the U.S. Senate on August 7. Those topics include the implications of allowing Medicare to negotiate prices directly with drug manufacturers for some medications, capping Medicare Part D out-of-pocket costs, and continuing enhanced health insurance subsidies for people who buy insurance through Affordable Care Act exchanges."
  }
}